Skip to content

Seeger Weiss Reports Enrollment of 93% of Eligible Plaintiffs in VIOXX Settlement

Seeger Weiss LLP, announced today that 93 percent of eligible individuals have enrolled in the nationwide VIOXX settlement program first announced last November. Under the program, Merck has set aside $4.85 billion to compensate those claimants who suffered a heart attack, ischemic stroke, or sudden cardiac death while taking the drug. Seeger Weiss founding partner, […]

March 3, 2008

Seeger Weiss LLP, announced today that 93 percent of eligible individuals have enrolled in the nationwide VIOXX settlement program first announced last November. Under the program, Merck has set aside $4.85 billion to compensate those claimants who suffered a heart attack, ischemic stroke, or sudden cardiac death while taking the drug.

Seeger Weiss founding partner, Chris Seeger, who was one of the chief negotiators of the settlement, has over the last several months joined other attorneys from Seeger Weiss and the Plaintiffs Negotiating Committee in meeting with lawyers from around the country to guide them through the enrollment process. Given his intimate knowledge of the proceedings, Mr. Seeger is not surprised by the settlement program’s success, stating: ‘While the size and scope of the program is one of the largest and most complex of any pharmaceutical litigation in history, the high rate of enrollment is unprecedented and represents a decisive endorsement of its fairness.’

Mr. Seeger and his firm have been one of the nation’s leaders in the Vioxx litigation since 2001, serving as lead counsel in two trials, resulting in a $47.5 million verdict for the plaintiff in that case, and Co-Lead Counsel for the Plaintiffs Steering Committee in the federal litigation before the Honorable E. Eldon Fallon. His partner, David Buchanan, serves as Co-Liaison Counsel in the New Jersey Vioxx Litigation.

Under the program, those claimants enrolling in the program by February 29, 2008, may qualify to receive an early interim payment of their settlement proceeds. Mr. Seeger and his co-counsel will continue to work with attorneys and the program administrators to facilitate enrollment.

Related News

March 14, 2023
Seeger Weiss Obtains $10 Million Settlement In Whistleblower Lawsuit Against Medical Device Company Stimwave

New York, NY– Today, the Department of Justice announced a $10 million settlement with Florida-based medical device company Stimwave, and a criminal indictment charging former CEO Laura Perryman in connection with a scheme to create and sell a non-functioning dummy medical device for implantation into patients suffering from chronic pain.  The scheme resulted in millions […]

Read More
February 28, 2023
Eleven Seeger Weiss Partners Selected For Lawdragon 500 Leading Plaintiff Consumer Lawyers List

Seeger Weiss is proud to announce that eleven of the firm’s partners were selected for Lawdragon 500 Leading Plaintiff Consumer Lawyers list for 2023. This list celebrates attorneys who are “tenacious advocates and dogged pursuers of justice,” a description fitting for these accomplished members of the Seeger Weiss team. Founding partners Chris Seeger and Stephen […]

Read More
February 9, 2023
Former NFL Players File Class Action Lawsuit Against NFL Disability Plans, Board, Commissioner Roger Goodell For Systemic Bias Against Disabled Players

New data suggest “neutral” NFL-hired doctors who deny more claims receive higher compensation. Baltimore, MD – Former NFL players today filed a class action lawsuit against The NFL Player Disability & Survivor Benefit Plan and NFL Player Disability & Neurocognitive Benefits Plan (the Plan), the Disability Board that administers the Plan, and each of the […]

Read More